Actively Recruiting
Magnetoencephalography by Optical Pumping Magnetometer
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2025-05-28
70
Participants Needed
1
Research Sites
155 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
MagnetoEncephaloGraphy (MEG) is a method of recording brain activity with high temporal resolution and good spatial resolution, compared to current recording techniques such as ElectroEncephaloGraphy (EEG). The main limitation of MEG is its cost due to the sensors used, the Super Quantum Interference Devices (SQUID). These require a complex infrastructure from an instrumentation point of view to operate, requiring liquid helium, most often at a loss, at increasing cost. Optical Pumping Magnetometers (OPM) type sensors represent a promising alternative to SQUIDs sensors, especially since they do not require helium cooling. The purpose of this project is to Identify biomarkers in Magnetoencephalography of normal brain development in healthy adults, premature and term newborns from "a priori" obtained by the classical technique of High Resolution EEG performed.
CONDITIONS
Official Title
Magnetoencephalography by Optical Pumping Magnetometer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy adult volunteers aged 18 to 65 years
- No current illness or treatment
- No intake of toxic substances
- Term newborns between 38 and 42 weeks gestational age on the day of registration
- No illness or treatment
- Premature newborns between 28 and 36 weeks gestational age on the day of registration
- No illness or treatment except routine prematurity care
- Pregnant women between 28 and 40 weeks gestational age on the day of registration
- No illness or treatment
You will not qualify if you...
- Presence of prosthesis or pacemaker that may interfere with MEG measurement
- Inability to remain still for a few minutes during measurement
- Newborns requiring ventilatory assistance or infusion
- Newborns not meeting the specified age criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Amiens
Amiens, France, 80054
Actively Recruiting
Research Team
F
Fabrice Wallois, Pr
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here